动脉狭窄症:基于OMIC的目标发现和治疗开发

Mark C Blaser1, Magnus Bäck2,3, Thomas F Lüscher4,5,6

  • 1Center for Interdisciplinary Cardiovascular Sciences, Brigham and Women's Hospital, Harvard Medical School, 3 Blackfan Street, 17th Floor, Boston, MA 02115, USA.

European heart journal
|December 10, 2024
PubMed
概括

甲状腺膜疾病 (CAVD) 导致甲状腺狭窄症 (AS),这是一个常见的心脏病. 多omics研究揭示了分子机制和新疗法的潜在药物标,改善了患者的治疗结果.